News and Announcements
Imugene’s Cancer Vacine Recieves Grant Notice from Canadian Patent Office
- Published August 18, 2017 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Imugene Limited (ASX:IMU) has recently announced news it has received notice that the Canadian Patent Office has issued a Grant Notice for the Company’s cancer vaccine HER-Vaxx.
KEY TAKEAWAYS:
- Canadian Patent Office has issued Grant Notice for Imugene’s patent application protecting its cancer vaccine “HER-Vax”
- Patent will protect specific cancer vaccine formulations of commercial interest
HER-Vaxx works by targeting the same receptor as Herceptin and Perjeta, two of the leading drugs on the market, with annual sales of US$8.2 billion. The mechanism of action for HER-Vaxx may help generate improved efficacy over existing treatments and at a lower cost.
Company Updates
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
Backed By Leading Investment Groups and Family Offices
